Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2000
12/21/2000WO2000076518A1 Urea substituted imidazoquinolines
12/21/2000WO2000076517A1 Il-8 receptor antagonists
12/21/2000WO2000076516A1 Il-8 receptor antagonists
12/21/2000WO2000076515A1 Il-8 receptor antagonists
12/21/2000WO2000076505A1 Amide substituted imidazoquinolines
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076501A1 Il-8 receptor antagonists
12/21/2000WO2000076495A1 Il-8 receptor antagonists
12/21/2000WO2000076481A1 Mesalazine controlled release oral pharmaceutical compositions
12/21/2000WO2000076470A1 Synergistic antibacterial combination
12/21/2000WO2000076457A2 Il-8 receptor antagonists
12/21/2000WO2000076452A2 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000WO2000066736B1 Growth factor homolog zvegf4
12/21/2000WO2000053581A3 Heterocyclic compounds having antitumor activity
12/21/2000WO2000053030A3 Pet food product with coconut endosperm fibre
12/21/2000WO2000050062A3 Methods and compositions for altering mucus secretion
12/21/2000WO2000047580A3 Phenyl urea and phenyl thiourea derivatives
12/21/2000WO2000046240A3 Polypeptides involved in immune response
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/21/2000WO2000038660A3 Use of bisphosphonates for the prevention and treatment of infectious processes
12/21/2000WO2000007577A8 Phosphatidylcholine as a medicament for the protection of mucosa
12/21/2000DE19927574A1 Increasing content of flavonoids and phenols in plants, useful for e.g. preventing cardiovascular disease, by reducing activity of flavanone-3-hydroxylase
12/21/2000CA2689997A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2387696A1 48 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382185A1 48 human secreted proteins
12/21/2000CA2381322A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2379048A1 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative
12/21/2000CA2377397A1 Il-8 receptor antagonists
12/21/2000CA2377391A1 Il-8 receptor antagonists
12/21/2000CA2377386A1 Il-8 receptor antagonists
12/21/2000CA2377341A1 Il-8 receptor antagonists
12/21/2000CA2377320A1 Methods for modulating fxr receptor activity
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376851A1 Synergistic antibacterial combination
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376667A1 Gene expression modulated in gastrointestinal inflammation
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376296A1 Urea substituted imidazoquinolines
12/21/2000CA2375920A1 Compounds
12/21/2000CA2375878A1 Dithiepino[6,5-b]pyridines, and related compositions and methods
12/21/2000CA2375848A1 Optically active pyrrolopyridazine compounds
12/21/2000CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/21/2000CA2374239A1 Substituted heterocycle fused gamma-carbolines
12/21/2000CA2373920A1 Substituted heterocycle fused gamma-carbolines
12/20/2000EP1060192A2 Glp-2 derivatives with helix-content exceeding 25 %, forming partially structured micellar-like aggregates
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060182A2 Novel prodrugs for phosphorus-containing compounds
12/20/2000EP1060181A1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
12/20/2000EP1060171A2 Tryptase inhibitors
12/20/2000EP1060162A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
12/20/2000EP1060161A1 Matrix metalloproteinase inhibitors
12/20/2000EP1059943A1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
12/20/2000EP0938309A4 Methods for in vivo reduction of iron levels and compositions useful therefor
12/20/2000EP0671934B1 Method of treating cell damage or depletion
12/20/2000CN1277613A Poly (ADP-ribose) polymerase ('PARP') inhibitors, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage
12/20/2000CN1277611A 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
12/20/2000CN1277604A Heteraryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/20/2000CN1277050A Liver ascites treating medicine
12/20/2000CN1277044A Preparation of serial healthy foods with peach blossom, pearl and ant
12/20/2000CN1277029A Chewing gum for treating allergic toothache and its preparation
12/20/2000CN1277026A Pain-relieving, bleeding-stopping and itching-stopping antibacterial medicine
12/20/2000CN1277020A Application of Eight precious extract in preparing antiviral medicine
12/20/2000CN1059595C Method for producing preparation for piles
12/20/2000CN1059586C Tooth-care article
12/20/2000CN1059580C Sikang yangsheng health-care tablet
12/20/2000CN1059578C Medicine for treating cholelithiosis
12/20/2000CN1059574C Chinese herb medicine preparation for treating cirrhosis for internal and external use
12/20/2000CN1059569C Vertigo-relieving tablet and its producing process
12/20/2000CN1059564C Powder for fast painless tooth extraction
12/19/2000US6162830 Antihistamines, antiallergens, bone disorders
12/19/2000US6162826 Genipin derivative having anti hepatitis B virus activity
12/19/2000US6162819 Pyrazole derivatives, their preparation and their use in pharmaceuticals
12/19/2000US6162818 Respiratory system disorders; crohn's disorder; cardiovascular disorders
12/19/2000US6162817 Stroke therapy; brain disorders; crohn's disease
12/19/2000US6162816 Antisecretory, antiulcer agents
12/19/2000US6162808 Compounds
12/19/2000US6162792 Use of spiramycin for treating gastrointestinal disorders caused by H. pylori
12/19/2000US6162790 Oligopeptides
12/19/2000US6162600 Indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/19/2000US6162464 Non-aqueous colonic purgative formulations
12/19/2000CA2189527C Novel elastase inhibitors
12/19/2000CA2145881C Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075290A1 Method for multiplying stem cells
12/14/2000WO2000075284A1 A bacterial strain, processed plant extracts and probiotic compositions for human and veterinary use
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075275A2 Bioreactor design and process for engineering tissue from cells
12/14/2000WO2000075191A2 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075139A2 Benzothiazinone and benzoxazinone compounds
1 ... 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 ... 1258